ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax.

Toshihisa Satta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.